Study to Confirm the Efficacy and Safety of Fixed-dose Combinations of Amlodipine and Candesartan
Status:
Unknown status
Trial end date:
2019-05-31
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of amlodipine besylate and candesartan cilexetil
administered in a fixed-dose combination tablet versus co-administered as their separate
formulations in patients with essential hypertension who have shown inadequate response on
monotherapy of amlodipine or candesartan cilexetil or who are with blood pressure adequately
controlled by co-administration of amlodipine besylate and candesartan cilexetil single
agents